Multiple studies have consistently confirmed that inhibiting the expression of mTOR and its downstream target genes has a pronounced effect on halting the malignant progression of breast cancer (Soulard and Hall, 2007; Goel et al., 2022). The gene discussed is MTOR; the disease is breast carcinoma.